SCI时时刷

search
+
Use of serum BCMA levels to predict outcomes for myeloma patients treated with ruxolitinib, lenalidomide and methylprednisolone
Use of serum BCMA levels to predict outcomes for myeloma patients treated with ruxolitinib, lenalidomide and methylprednisolone
Abstract Previous retrospective studies have shown that serum B-cell maturation (sBCMA) levels predict outcomes among pati...
Native E. coli asparaginase upfront should be replaced by PEGasparaginase upfront in the treatment of pediatric patients with acute lymphoblastic leukemia
Native E. coli asparaginase upfront should be replaced by PEGasparaginase upfront in the treatment of pediatric patients with acute lymphoblastic leukemia
Corresponding Author Wing H. Tong Department of Public Hea...
Cardiotoxicity As An Adverse Effect Of Immunomodulatory Drugs And Proteasome Inhibitors In Multiple Myeloma: A Network Meta‐analysis Of Randomized Clinical Trials
Cardiotoxicity As An Adverse Effect Of Immunomodulatory Drugs And Proteasome Inhibitors In Multiple Myeloma: A Network Meta‐analysis Of Randomized Clinical Trials
Abstract: We aim to determine the cumulative and comparative risk of cardiovascular events associated with different Immun...
Efficacy and follow‐up of humanized anti‐BCMA CAR‐T cell therapy in relapsed/refractory multiple myeloma patients with extramedullary‐extraosseous, extramedullary‐bone related, and without extramedullary disease
Efficacy and follow‐up of humanized anti‐BCMA CAR‐T cell therapy in relapsed/refractory multiple myeloma patients with extramedullary‐extraosseous, extramedullary‐bone related, and without extramedullary disease
SummaryThe prognosis of patients with multiple myeloma (MM) with extramedullary disease (EMD) remains poor. A high overall...
SARS‐CoV‐2 Vaccine Response in CAR T‐cell Therapy Recipients: A Systematic Review and Preliminary Observations
SARS‐CoV‐2 Vaccine Response in CAR T‐cell Therapy Recipients: A Systematic Review and Preliminary Observations
Abstract: Evolving data suggest that SARS-CoV-2 vaccine responses are blunted in allogeneic HCT recipients. Responses to t...
Circulating Exosomal MicroRNAs as Diagnostic and Prognostic Biomarkers in Patients with Diffuse Large B‐Cell Lymphoma
Circulating Exosomal MicroRNAs as Diagnostic and Prognostic Biomarkers in Patients with Diffuse Large B‐Cell Lymphoma
Abstract Background Exosomal microRNAs (miRNAs) are potential biomarkers for a variety of tumors but have not yet been stu...
First external validation of the FLIPI‐L score in a single‐center series of patients with follicular lymphoma
First external validation of the FLIPI‐L score in a single‐center series of patients with follicular lymphoma
Abstract The FLIPI-L has recently been proposed as a novel prognostic index in follicular lymphoma (FL), combining FLIPI a...
Outcome of patients with mantle cell lymphoma after autologous stem cell transplantation in the pre‐CAR T‐cell era
Outcome of patients with mantle cell lymphoma after autologous stem cell transplantation in the pre‐CAR T‐cell era
Abstract Mantle cell lymphoma (MCL) patients can be treated with intensive induction therapy, followed by high dose chemot...
Evaluation of prognostic staging systems of multiple myeloma in the era of novel agents
Evaluation of prognostic staging systems of multiple myeloma in the era of novel agents
Abstract This study aimed to evaluate the existing staging systems for multiple myeloma (MM) in the real world. From Janua...
Synergistic Anticancer Effect of a Combination of Chidamide and Etoposide Against NK/T Cell Lymphoma
Synergistic Anticancer Effect of a Combination of Chidamide and Etoposide Against NK/T Cell Lymphoma
AbstractNatural killer/T cell lymphoma (NKTCL) is a highly aggressive hematological malignancy. However, there is currentl...
First external validation of the FLIPI‐L score in a single‐centre series of patients with follicular lymphoma
First external validation of the FLIPI‐L score in a single‐centre series of patients with follicular lymphoma
AbstractThe FLIPI-L has recently been proposed as a novel prognostic index in follicular lymphoma (FL), combining FLIPI an...
Outcome of patients with mantle cell lymphoma after autologous stem cell transplantation in the pre‐CAR T‐cell era Letter
Outcome of patients with mantle cell lymphoma after autologous stem cell transplantation in the pre‐CAR T‐cell era Letter
Abstract Introduction Mantle cell lymphoma (MCL) patients can be treated with intensive induction therapy, followed by hig...
CEBPA Are Independent Good Prognostic Factors in Pediatric Acute Myeloid Leukemia
CEBPA Are Independent Good Prognostic Factors in Pediatric Acute Myeloid Leukemia
Abstract Purpose To evaluate the outcome and prognostic significance of CEBPA mutations among pediatric acute myeloid leuk...
Differential transcriptomic profiling in ibrutinib‐naïve versus ibrutinib‐resistant Richter syndrome
Differential transcriptomic profiling in ibrutinib‐naïve versus ibrutinib‐resistant Richter syndrome
Corresponding Author Division of Hematology, Mayo Clinic, Rochester, MN, USA ...
Downregulation of FAPP2 gene induces cell autophagy and inhibits PI3K/AKT/mTOR pathway in T‐cell acute lymphoblastic leukemia
Downregulation of FAPP2 gene induces cell autophagy and inhibits PI3K/AKT/mTOR pathway in T‐cell acute lymphoblastic leukemia
AbstractT-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy. Most patients with T-ALL ar...
Salvage therapy with “Dara‐KDT‐P(A)CE” in heavily pretreated, high‐risk, proliferative, relapsed/refractory Multiple Myeloma
Salvage therapy with “Dara‐KDT‐P(A)CE” in heavily pretreated, high‐risk, proliferative, relapsed/refractory Multiple Myeloma
Abstract The multi-agent therapy “VDT-PACE” represents an established regimen in RRMM. Here, we report on ou...
Treatment strategies for a rapidly evolving landscape in chronic lymphocytic leukemia management
Treatment strategies for a rapidly evolving landscape in chronic lymphocytic leukemia management
Abstract With the advent of targeted therapies for chronic lymphocytic leukemia (CLL), treatment choice has expanded and p...
Elastin MIcrofibriL INterfacer1 (EMILIN‐1) is an alternative prosurvival VLA‐4 ligand in chronic lymphocytic leukemia
Elastin MIcrofibriL INterfacer1 (EMILIN‐1) is an alternative prosurvival VLA‐4 ligand in chronic lymphocytic leukemia
ABSTRACT CD49d, the α4 chain of the VLA-4 integrin, is a negative prognosticator in chronic lymphocytic leukemia (CL...
Post‐relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantation
Post‐relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantation
AbstractWaldenström macroglobulinemia (WM) is a rare B-cell lymphoproliferative malignancy. Autologous hematopoietic ...
Immunophenotype of Acute Lymphoblastic Leukemia in Minorities‐ Analysis from the SEER database
Immunophenotype of Acute Lymphoblastic Leukemia in Minorities‐ Analysis from the SEER database
Abstract Acute Lymphocytic Leukemia (ALL) is a malignancy that originates from immature lymphoid cells and is clinically e...
Review on natural killer /T‐cell lymphoma
Review on natural killer /T‐cell lymphoma
Abstract Extranodal natural killer (NK)/T-cell lymphoma (ENKTL) is strongly associated with Epstein-Barr virus (EBV) and h...
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R‐CHOP14: A SAKK 38/07 trial post‐hoc analysis
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R‐CHOP14: A SAKK 38/07 trial post‐hoc analysis
Abstract Functional parameters from positron emission tomography (PET) seem promising biomarkers in various lymphoma subty...
Pre‐treatment health‐related quality of life parameters have prognostic impact in patients > 65 years with newly diagnosed mantle cell lymphoma. The Nordic Lymphoma Group MCL4 (LENA‐BERIT) experience.
Pre‐treatment health‐related quality of life parameters have prognostic impact in patients > 65 years with newly diagnosed mantle cell lymphoma. The Nordic Lymphoma Group MCL4 (LENA‐BERIT) experience.
Abstract Mantle cell lymphoma (MCL) is a rare, often aggressive type of B-cell lymphoma with poor survival and no cure. Ca...
Treatment strategies for a rapidly evolving landscape in chronic lymphocytic leukaemia management
Treatment strategies for a rapidly evolving landscape in chronic lymphocytic leukaemia management
Abstract Purpose of this review With the advent of targeted therapies for chronic lymphocytic leukaemia (CLL), treatment c...
Diagnostic utility of bronchoscopy in newly diagnosed acute leukemia patients
Diagnostic utility of bronchoscopy in newly diagnosed acute leukemia patients
Abstract Pulmonary infections and acute respiratory failure remain a significant cause of morbidity and mortality in newly...
Large granular lymphocytosis: a novel association with immunotherapy.
Large granular lymphocytosis: a novel association with immunotherapy.
Abstract Although reactive large granular lymphocytosis due to diverse etiologies is not an uncommon finding in clinical p...
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: a Fondazione Italiana Linfomi real‐life experience.
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: a Fondazione Italiana Linfomi real‐life experience.
Abstract The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed b...
LINC00152 expression in normal and Chronic Lymphocytic Leukemia B cells
LINC00152 expression in normal and Chronic Lymphocytic Leukemia B cells
ABSTRACTLong non-coding RNAs (lncRNAs) are emerging as essential regulators of gene expression, but their role in normal a...
Poor survival and prediction of prolonged isolated thrombocytopenia post umbilical cord blood transplantation in patients with hematological malignancies
Poor survival and prediction of prolonged isolated thrombocytopenia post umbilical cord blood transplantation in patients with hematological malignancies
Abstract Prolonged isolated thrombocytopenia (PIT) is a common complication after umbilical cord blood transplantation (UC...
Global burden and attributable risk factors of acute lymphoblastic leukemia in 204 countries and territories in 1990‐2019: estimation based on Global Burden of Disease Study 2019
Global burden and attributable risk factors of acute lymphoblastic leukemia in 204 countries and territories in 1990‐2019: estimation based on Global Burden of Disease Study 2019
Abstract To provide a foundational guideline for policy-makers to efficiently allocate medical resources in the context of...
阅读更多
format_indent_increase